Clinical trial
Study To Evaluate GSK256066 In Subjects With Mild Bronchial Asthma
NCT00380354 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00380354 |
|---|---|
| Title | Study To Evaluate GSK256066 In Subjects With Mild Bronchial Asthma |
| Official title | A Two-centre, Randomised, Double-blind, Placebo-controlled, 2-period Cross-over Study to Evaluate the Effect of Treatment With Repeat Doses of Inhaled GSK256066 on the Allergen-induced Late Asthmatic Response in Subjects With Mild Asthma |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma, Mild Asthma |
| Intervention type | Drug |
| Interventions | GSK256066 |
| Enrollment | 11 |
| Start date | Sep 1, 2006 |
| Completion | Jun 1, 2007 |
| First posted | Sep 25, 2006 |
| Last update posted | Jun 4, 2012 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: